Skip navigation
University library of Heidelberg
Please note that your choice of borrowing branch library affects which collection points you will be offered when ordering or reserving items. It is also relevant for deciding the loan status of items ('for loan', 'for order', etc.)
+ Search history (1 Search)
DigiKat (1936-1961): - Parallel search in Digikat is still running... RSSDrucker
Folder
|<  [1-20]  [21-40]  [41-60]  [61-80]  [81-100] ... >|
sort by: 
No subject group preferred

Refine results:

81 doc. < 1825
 to  
 
1. Botta, Cirino: Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance / Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, Maria-Teresa Cedena, Rosalinda Termini, Ib… , 20 September 2023. - 15 S.
In: Nature Communications, ISSN 2041-1723. 14(2023), Artikel-ID 5825, Seite 1-15
DOI: 10.1038/s41467-023-41562-6
Online resource Journal article 
UB HD verfügbar?
2. Termini, Rosalinda: Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma / Rosalinda Termini, David Žihala, Evangelos Terpos, Albert Perez-Montaña, Tomáš Jelínek, Marc Raab, N… , 1 November 2022. - 11 S.
In: Clinical cancer research, ISSN 1557-3265. 28(2022), 21, Seite 4771-4781
DOI: 10.1158/1078-0432.CCR-22-1594
Online resource Journal article 
UB HD verfügbar?
3. Botta, Cirino: FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology / Cirino Botta, Catarina Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Le… , 24 January 2022. - 14 S.
In: Blood advances, ISSN 2473-9537. 6(2022), 2, Seite 690-703
DOI: 10.1182/bloodadvances.2021005198
Online resource Journal article 
UB HD verfügbar?
4. Facon, Thierry: Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA) : overall survival results from a randomised, open-label, phase 3 trial / Thierry Facon, Shaji K. Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar Bahlis, Su… , 13 October 2021. - 15 S.
In: The lancet, ISSN 1474-5488. 22(2021), 11, Seite 1582-1596
DOI: 10.1016/S1470-2045(21)00466-6
Online resource Journal article 
UB HD verfügbar?
5. Mateos, Maria-Victoria: Comparative efficacy of teclistamab versus physician's choice of therapy in the long-term follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS clinical trials in patients with triple-class exposed relapsed or refractory multiple myeloma / María-Victoria Mateos, Ajai Chari, Saad Z. Usmani, Hartmut Goldschmidt, Katja Weisel, Keqin Qi, Anil… , May 2023. - 9 S. : Illustrationen
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 23(2023), 5 vom: Mai, Seite 385-393
DOI: 10.1016/j.clml.2023.02.006
Online resource Journal article 
UB HD verfügbar?
6. Moreau, Philippe: Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma : matching-adjusted indirect comparison / Philippe Moreau, Benjamin Hebraud, Thierry Facon, Xavier Leleu, Cyrille Hulin, Mahmoud Hashim, Yanna… , February 2021. - 12 S.
In: Immunotherapy, ISSN 1750-7448. 13(2021), 2 vom: Feb., Seite 143-154
DOI: 10.2217/imt-2020-0266
Online resource Journal article 
UB HD verfügbar?
7. Mateos, Maria-Victoria: Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183) : a randomised, open-label, phase 3 trial / Maria-Victoria Mateos, MD, Hilary Blacklock, MBChB, Fredrik Schjesvold, MD, Albert Oriol, MD, David… , 18 July 2019. - 11 S.
In: The lancet, ISSN 2352-3026. 6(2019), 9, Seite e459-e469
DOI: 10.1016/S2352-3026(19)30110-3
Online resource Journal article 
UB HD verfügbar?
8. Facon, Thierry: Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma / Thierry Facon, Shaji K Kumar, Torben Plesner, Robert Z Orlowski, Philippe Moreau, Nizar Bahlis, Supr… , Apr 2023. - 9 S. : Illustrationen
In: Future oncology, ISSN 1744-8301. 19(2023), 13 vom: Apr., Seite 887-895
DOI: 10.2217/fon-2023-0082
Online resource Journal article 
UB HD verfügbar?
9. Moreau, Philippe: Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression–Related Death / Philippe Moreau, Michele Cavo, Pieter Sonneveld, Laura Rosinol, Michel Attal, Annalisa Pezzi, Hartmu… , 10 July 2014. - 11 S.
In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 20, Seite 2173-2183
DOI: 10.1200/JCO.2013.53.0329
Online resource Journal article 
UB HD verfügbar?
10. Schreiner, Sarah: Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma / Sarah Schreiner, Natalie Berghaus, Alexandra M. Poos, Marc S. Raab, Britta Besemer, Roland Fenk, Har… , 11 Jan 2024. - 9 S. : Illustrationen
In: Amyloid, ISSN 1744-2818. (2024), online ahead of print
DOI: 10.1080/13506129.2023.2295221
Online resource Journal article 
UB HD verfügbar?
11. Leypoldt, Lisa: Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the treatment of high-risk newly diagnosed multiple myeloma / Lisa B. Leypoldt, MD, Diana Tichy, MD, Britta Besemer, MD, Mathias Hänel, MD, Marc S. Raab, MD, Chri… , January 2024. - 21 S.
In: Journal of clinical oncology, ISSN 1527-7755. 42(2024), 1 vom: Jan., Seite 26-37
DOI: 10.1200/JCO.23.01696
Online resource Journal article 
UB HD verfügbar?
12. Mai, Elias K.: Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial / Elias K Mai, Hartmut Goldschmidt, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Julia Krzyk… , February 2024. - 13 S.
In: The lancet, ISSN 2352-3026. 11(2024), 2, Seite e101-e113
DOI: 10.1016/S2352-3026(23)00366-6
Online resource Journal article 
UB HD verfügbar?
13. Kriegsmann, Katharina: Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM / Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias K. Mai, Marc S. Raab, Hans J. Salwender, Ro… , January 27, 2023. - 5 S.
In: Blood advances, ISSN 2473-9537. 7(2023), 3 vom: Jan., Seite 379-383
DOI: 10.1182/bloodadvances.2022008005
Online resource Journal article 
UB HD verfügbar?
14. Giesen, Nicola: A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma / Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel… , April 6, 2023. - 6 S.
In: Blood, ISSN 1528-0020. 141(2023), 14 vom: Apr., Seite 1685-1690
DOI: 10.1182/blood.2022017789
Online resource Journal article 
UB HD verfügbar?
15. Mai, Elias K.: Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients / Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Sonja Zweegman, Marc S. Raab, Markus… , 07 December 2023. - 8 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. (2023), Seite 1-8
DOI: 10.1038/s41375-023-02105-6
Online resource Journal article 
UB HD verfügbar?
16. Wennmann, Markus: Prediction of bone marrow biopsy results from MRI in multiple myeloma patients using deep learning and radiomics / Markus Wennmann, Wenlong Ming, Fabian Bauer, Jiri Chmelik, André Klein, Charlotte Uhlenbrock, Martin… , October 2023. - 12 S.
In: Investigative radiology, ISSN 1536-0210. 58(2023), 10 vom: Okt., Seite 754-765
DOI: 10.1097/RLI.0000000000000986
Online resource Journal article 
UB HD verfügbar?
17. Leypoldt, Lisa: Daratumumab, Bortezomib, and Dexamethasone for treatment of patients with relapsed or refractory multiple myeloma and severe renal impairment : results from the phase 2 GMMG-DANTE trial / Lisa B. Leypoldt, Maria Gavriatopoulou, Britta Besemer, Hans Salwender, Marc S. Raab, Axel Nogai, Cy… , 2023. - 13 S.
In: Cancers, ISSN 2072-6694. 15(2023), 18, Artikel-ID 4667, Seite 1-13
DOI: 10.3390/cancers15184667
Online resource Journal article 
UB HD verfügbar?
18. Waszczuk-Gajda, Anna: Complications of autologous stem cell transplantation in multiple myeloma : results from the CALM study / Anna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, Linda Koster, Didier Blaise, Péter Reményi, Nigel… , 20 June 2022. - 10 S.
In: Journal of Clinical Medicine, ISSN 2077-0383. 11(2022), 12, special issue, Artikel-ID 3541, Seite 1-10
DOI: 10.3390/jcm11123541
Online resource Journal article 
UB HD verfügbar?
19. Jagannath, Sundar: KarMMa-RW : comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma / Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, Donna Reece, Ajay Nooka, Alicia Senin, Paula Rodrigue… , 18 June 2021. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 11(2021), Artikel-ID 116, Seite 1-9
DOI: 10.1038/s41408-021-00507-2
Online resource Journal article 
UB HD verfügbar?
20. Lawless, Sarah: IgD subtype but not IgM or non-secretory is a prognostic marker for poor survival following atologous hematopoietic cell transplantation in multiple myeloma : results from the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) study / Sarah Lawless, Jiulia Sbianchi, Curly Morris, Simona Iacobelli, Paul Bosman, Didier Blaise Péter Rem… , 24 May 2021. - 15 S.
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 21(2021), 10 vom: Okt., Seite 686-693
DOI: 10.1016/j.clml.2021.05.012
Online resource Journal article 
UB HD verfügbar?
Folder
|<  [1-20]  [21-40]  [41-60]  [61-80]  [81-100] ... >|
Library holdings published up to 1961 see also DigiKat.
zum Seitenanfang